International Assets Investment Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Sell |
10,614
-16,970
| -62% | -$450K | 0.02% | 633 |
|
|
2025
Q1 | $666K | Buy |
27,584
+9,308
| +51% | +$225K | 0.06% | 332 |
|
|
2024
Q4 | $752K | Sell |
18,276
-985,757
| -98% | -$40.5M | 0.06% | 295 |
|
|
2024
Q3 | $15.9K | Buy |
1,004,033
+994,801
| +10,776% | +$15.7K | 0.04% | 323 |
|
|
2024
Q2 | $489K | Buy |
9,232
+2,756
| +43% | +$146K | 0.05% | 370 |
|
|
2024
Q1 | $515K | Sell |
6,476
-13,492
| -68% | -$1.07M | 0.05% | 363 |
|
|
2023
Q4 | $372K | Sell |
19,968
-2,450
| -11% | -$45.6K | 0.05% | 416 |
|
|
2023
Q3 | $245K | Sell |
22,418
-8,820
| -28% | -$96.3K | 0.03% | 438 |
|
|
2023
Q2 | $506K | Buy |
31,238
+31,135
| +30,228% | +$505K | 0.07% | 271 |
|
|
2023
Q1 | $1.72K | Buy |
+103
| New | +$1.72K | ﹤0.01% | 1009 |
|